Bottom line
FHLC vs PINK: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.
But FHLC is far broader, holding 337 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
FHLC is cheaper at 0.084% vs 0.51% — a difference of $43 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +2.6% for FHLC (reporting dates differ).
Updated Nov 19, 2026
FHLC vs PINK side by side
| FHLC | PINK | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Fidelity | Simplify Exchange Traded |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.51% |
| Annual cost per $10k | $8.4 | $51 |
| 10-yr cost on $10k (prospectus) | $108 | $641 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.6% | +24.1% |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | +16.4% | +15.6% |
| Worst quarter | −13.1% | −9.5% |
| Net assets (fund) | $3.3B | $358.6M |
| Number of holdings | 337 | 54 |
| Portfolio turnover | 3% | 171% |
| Returns as of | Nov 30, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | PINK | Difference |
|---|---|---|---|
| 2024 | +2.6% | +8.9% | −6.3% |
| 2023 | +2.5% | +3.8% | −1.3% |
| 2022 | −5.5% | −4.3% | −1.2% |
Source: Fund prospectus bar charts
Holdings overlap
12 of FHLC's top 25 holdings also appear in PINK's top 25.
| Holding | FHLC | PINK |
|---|---|---|
| Eli Lilly & Co | 13.35% | 5.91% |
| Johnson & Johnson | 8.93% | 5.45% |
| AbbVie Inc | 6.42% | 4.52% |
| UnitedHealth Group Inc | 5.44% | 5.76% |
| Thermo Fisher Scientific Inc | 3.09% | 3.23% |
| Amgen Inc | 3.00% | 2.12% |
| Gilead Sciences Inc | 2.34% | 2.87% |
| CVS Health Corp | 1.92% | 2.01% |
| Danaher Corp | 1.80% | 2.28% |
| Vertex Pharmaceuticals Inc | 1.76% | 1.45% |
| Elevance Health Inc | 1.19% | 2.73% |
| Cardinal Health Inc | 0.78% | 1.78% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
FAQ
What is the difference between FHLC and PINK?
Which is cheaper, FHLC or PINK?
Should I own both FHLC and PINK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.